This Pharmaceutical Industry Investment Plays a $166 Billion Trend

The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015. According to PricewaterhouseCoopers , the "life sciences" field had 35 deals in Q1 2015. Those deals totaled $166.3 billion. That's more money than was spent during the entire year in 2014, when $150.1 billion was spent. In Q1 2014, just $46.5 billion was spent. Money Morning 's Defense and Tech Specialist Michael Robinson has been recommending a way to profit from the M&A boom throughout 2015. His pick has already climbed 12% in 2015, compared to just 2% for the Dow Jones. Here's why it will continue bringing profits in 2015... Tags: ETFs Article , pharma companies , pharma ETFs , pharma industry , pharma stocks , pharmaceutical companies , pharmaceutical ETFs , pharmaceutical industry , pharmaceutical stocks , top pharma companies , top pharma stock To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post This Pharmaceutical Industry Investment Plays a $166 Billion Trend appeared first on Money Morning - We Make Investing Profitable .